Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Human papillomavirus vaccine in boys: background rates of potential adverse events.

Clothier HJ, Lee KJ, Sundararajan V, Buttery JP, Crawford NW.

Med J Aust. 2013 Jun 3;198(10):554-8.

PMID:
23725271
2.

Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.

Gold MS, McIntyre P.

Sex Health. 2010 Sep;7(3):320-4. doi: 10.1071/SH09153.

PMID:
20719221
3.

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.

Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J.

JAMA. 2009 Aug 19;302(7):750-7. doi: 10.1001/jama.2009.1201.

PMID:
19690307

Supplemental Content

Loading ...
Write to the Help Desk